Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 3 · 60%High 0 · 0%

Neonatal tetanus deaths ‐ 1 dose · women aged between 13 and 45 years.

Tetanus toxoid showed no clear difference in neonatal tetanus deaths ‐ 1 dose compared with influenza vaccine (low certainty).

1 finding from 1 review

Vaccines for women for preventing neonatal tetanus 2015 · Cochrane Headline outcomes only
RR 0.57 [0.26, 1.24]
1 study · 494 participants
Low

Neonatal tetanus deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.

Tetanus toxoid probably leads to lower neonatal tetanus deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).

1 finding from 1 review

Vaccines for women for preventing neonatal tetanus 2015 · Cochrane Headline outcomes only
RR 0.02 [0, 0.3]
1 study · 688 participants
Moderate

All causes of deaths ‐ 1 dose · women aged between 13 and 45 years.

Tetanus toxoid showed no clear difference in all causes of deaths ‐ 1 dose compared with influenza vaccine (low certainty).

1 finding from 1 review

Vaccines for women for preventing neonatal tetanus 2015 · Cochrane Headline outcomes only
RR 1.08 [0.65, 1.79]
1 study · 494 participants
Low

All causes of deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.

Tetanus toxoid probably leads to lower all causes of deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).

1 finding from 1 review

Vaccines for women for preventing neonatal tetanus 2015 · Cochrane Headline outcomes only
RR 0.31 [0.17, 0.55]
1 study · 688 participants
Moderate

Neonatal tetanus cases ‐ Any dose · women aged between 13 and 45 years.

Tetanus toxoid probably leads to lower neonatal tetanus cases ‐ Any dose compared with influenza vaccine (moderate certainty).

1 finding from 1 review

Vaccines for women for preventing neonatal tetanus 2015 · Cochrane Headline outcomes only
RR 0.2 [0.1, 0.4]
1 study · 1182 participants
Moderate